Ewing sarcoma: historical perspectives, current state-of-the-art, and opportunities for targeted therapy in the future

This is the authors' abstract. We don't add key points for this paper.

With an improved understanding of the genome, transcriptome, proteome, and other '-omic' events that promote and sustain Ewing pathogenesis, the use of nascent biologically targeted therapeutics is on the horizon. Understanding how and when to integrate such therapies into clinical practice, although challenging, may lead to a paradigm shift towards more personalized therapy.

A review of Ewing sarcoma pathogenesis and the potential for future biologically targeted therapeutics to enable personalized therapy.